Ramish Maqsood
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ramish Maqsood has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Chandana Maji
Department of Pharmaceutical Chemistry, Noida Institute of Engineering and Technology (Pharmacy Institute), Knowledge Park-II, Greater Noida
1 shared publication - D. Akiladevi
Department of Pharmaceutics, School of Pharmaceutical Sciences, Vels Institute of Science Technology and Advanced Studies, Pallavaram, Chennai, Tamilnadu, India
1 shared publication - Divya Raj Singh
Department of Pharmacy Practice , Teerthanker Mahaveer College of Pharmacy, Teerthanker, Mahaveer University, Moradabad UP,India
1 shared publication - Fahad Khan
Department of Community Medicine, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences
1 shared publication Gayatri R. Katole
Nagpur College of pharmacy, wanadongri, Hingna road, Nagpur, Maharashtra, India
1 shared publication- Gokul Vallimuthu
Saveetha College of Pharmacy, SIMATS, Thandalam, Chennai, Tamil Nadu, India
1 shared publication
Latest Publications
- Open Access
- 30 October 2026
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 5 (42) , 2202
Synthesis and Biological Evaluation of Coumarin Derivatives Targeting Oxidative Stress in Neurodegenerative Diseases
Neurodegenerative disorders, particularly Alzheimer’s disease, are closely associated with oxidative stress, cholinergic dysfunction, and progressive neuronal damage. In the present study, a series of coumarin derivatives (C1–C6) was designed, synthesized, and evaluated for their antioxidant and acetylcholinesterase inhibitory potential with the aim of identifying multifunctional lead compounds for neurodegenerative disorders. The coumarin scaffold was selected because of its well-established pharmacological versatility and its ability to accommodate structural modifications that may enhance biological activity. The synthesized derivatives were characterized by physicochemical analysis and Fourier-transform infrared spectroscopy, which confirmed the presence of characteristic functional groups such as hydroxyl, lactone carbonyl, aromatic C=C, and C–O moieties. Antioxidant activity was assessed using DPPH, ABTS, and ferric-reducing antioxidant power assays, while acetylcholinesterase inhibition was evaluated as a neurodegeneration-relevant target-based parameter. The results demonstrated that all compounds exhibited varying degrees of antioxidant and enzyme inhibitory activity depending on the nature of the substituents present on the coumarin nucleus. Among the tested derivatives, compound C4 showed the most promising overall biological profile, with comparatively lower IC₅₀ values in the DPPH and ABTS assays, higher ferric-reducing potential, and the strongest acetylcholinesterase inhibitory activity among the synthesized compounds. Structure–activity relationship analysis suggested that hydroxyl substitution significantly enhanced antioxidant activity, while appropriate electronic and steric features also contributed to enzyme inhibition. Overall, the findings indicate that rational modification of the coumarin scaffold can generate multifunctional derivatives with potential relevance in the management of oxidative stress-mediated neurodegenerative disorders. These results support further studies involving molecular docking, ADMET profiling, cellular models, and in vivo neuroprotective evaluation of the lead compound.
- 30 October 2026
- Published by Oriental Scientific Publishing Company in Oriental Journal of Chemistry
- Vol. 5 (42) , 2202
Open AccessSynthesis and Biological Evaluation of Coumarin Derivatives Targeting Oxidative Stress in Neurodegenerative Diseases
Neurodegenerative disorders, particularly Alzheimer’s disease, are closely associated with oxidative stress, cholinergic dysfunction, and progressive neuronal damage. In the present study, a series of coumarin derivatives (C1–C6) was designed, synthesized, and evaluated for their antioxidant and acetylcholinesterase inhibitory potential with the aim of identifying multifunctional lead compounds for neurodegenerative disorders. The coumarin scaffold was selected because of its well-established pharmacological versatility and its ability to accommodate structural modifications that may enhance biological activity. The synthesized derivatives were characterized by physicochemical analysis and Fourier-transform infrared spectroscopy, which confirmed the presence of characteristic functional groups such as hydroxyl, lactone carbonyl, aromatic C=C, and C–O moieties. Antioxidant activity was assessed using DPPH, ABTS, and ferric-reducing antioxidant power assays, while acetylcholinesterase inhibition was evaluated as a neurodegeneration-relevant target-based parameter. The results demonstrated that all compounds exhibited varying degrees of antioxidant and enzyme inhibitory activity depending on the nature of the substituents present on the coumarin nucleus. Among the tested derivatives, compound C4 showed the most promising overall biological profile, with comparatively lower IC₅₀ values in the DPPH and ABTS assays, higher ferric-reducing potential, and the strongest acetylcholinesterase inhibitory activity among the synthesized compounds. Structure–activity relationship analysis suggested that hydroxyl substitution significantly enhanced antioxidant activity, while appropriate electronic and steric features also contributed to enzyme inhibition. Overall, the findings indicate that rational modification of the coumarin scaffold can generate multifunctional derivatives with potential relevance in the management of oxidative stress-mediated neurodegenerative disorders. These results support further studies involving molecular docking, ADMET profiling, cellular models, and in vivo neuroprotective evaluation of the lead compound.
- Open Access
- 9 August 2025
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 4, 772
An Examination of the Application of Cannabis in Therapeutic Use for Parkinson's syndrome
The consequences of cannabis usage on Multiple Sclerosis (MS) and Parkinson's disease (PD) are still substantially uncertain despite recognizing that Cannabis was used for thousands of years as a medication. The evaluation of cannabis usage PD and MS, and a comparison of cannabis users' and non-users' self-reported assessments of neurological impairment were primary goals of this research. The survey contained standardized questions to collect information on demographics and Cannabis use questionnaires to evaluate participants' physical activity levels, neurological function, and weariness. Linear regression, Hierarchical Regression, and ANCOVA analysis of variance were employed in research. Were 900 respondents in a final data set. Cannabis consumers today were younger and less inclined to be considered fat. Regarding Emotional Variability, Cognitive Function, and Fatigue, cannabis users reported decreased degrees of disability. Cannabis may benefit PD and MS patients' Emotional Variability, Cognitive Function, Fatigue, and Physiological Weight. PD and MS patients' cannabis use: long-term advantages and downsides, and determining if these relationships are causal, more research is required to utilize longitudinally and clinically measured assessments among these domains.
- 9 August 2025
- Published by Salud, Ciencia y Tecnologia in Health Leadership and Quality of Life
- Vol. 4, 772
Open AccessAn Examination of the Application of Cannabis in Therapeutic Use for Parkinson's syndrome
The consequences of cannabis usage on Multiple Sclerosis (MS) and Parkinson's disease (PD) are still substantially uncertain despite recognizing that Cannabis was used for thousands of years as a medication. The evaluation of cannabis usage PD and MS, and a comparison of cannabis users' and non-users' self-reported assessments of neurological impairment were primary goals of this research. The survey contained standardized questions to collect information on demographics and Cannabis use questionnaires to evaluate participants' physical activity levels, neurological function, and weariness. Linear regression, Hierarchical Regression, and ANCOVA analysis of variance were employed in research. Were 900 respondents in a final data set. Cannabis consumers today were younger and less inclined to be considered fat. Regarding Emotional Variability, Cognitive Function, and Fatigue, cannabis users reported decreased degrees of disability. Cannabis may benefit PD and MS patients' Emotional Variability, Cognitive Function, Fatigue, and Physiological Weight. PD and MS patients' cannabis use: long-term advantages and downsides, and determining if these relationships are causal, more research is required to utilize longitudinally and clinically measured assessments among these domains.
- 1 May 2025
- Published by Bentham Science Publishers Ltd. in Reviews on Recent Clinical Trials
- Vol. 20 (2) , 79-95
Etiology, Recent Advances, and Clinical Trials Data for the Treatment of Angioedema: A Review
Angioedema is a health issue that affects parts of the body like the upper pulmonary and gastric pathways and is identified by abrupt, nonpitting enlargement of the skin, mucous membranes, or both. The swelling usually lasts a few hours to 72 hours and may appear as non-puritic, subcutaneous, or submucosal organ edema. It is characterized by localized swelling brought on by the release of histamine. Itching is rare, and usual areas of appearance include the hands, feet, face, and genitalia, with periorbital swelling being the most often. The main objective of this review article is to study in brief the classifications, etiology, pathophysiology, and clinical trial data by describing the recent advancement in the treatment of angioedema. Various research articles obtained from different journals indexed under Scopus and SCI were used to prepare the review article and for illustrative work software such as Biorender and Microsoft Word was used. Histaminemediated angioedema, linked to allergic reactions, coexists with urticaria. Bradykinin-mediated angioedema, exemplified by hereditary angioedema and acquired forms, lacks urticaria. Idiopathic angioedema, with uncertain etiology. Imitated angioedema results from non-IgE-mediated reactions, often induced by medications. It is a complicated medical condition with a variety of causes and mechanisms. Over time, outcomes for patients have been greatly improved by a growing understanding of its etiology, pathophysiology, and available treatments. The field of medical treatment for this difficult problem is always changing, and this is partly due to clinical trials.
- 1 May 2025
- Published by Bentham Science Publishers Ltd. in Reviews on Recent Clinical Trials
- Vol. 20 (2) , 79-95
Etiology, Recent Advances, and Clinical Trials Data for the Treatment of Angioedema: A Review
Angioedema is a health issue that affects parts of the body like the upper pulmonary and gastric pathways and is identified by abrupt, nonpitting enlargement of the skin, mucous membranes, or both. The swelling usually lasts a few hours to 72 hours and may appear as non-puritic, subcutaneous, or submucosal organ edema. It is characterized by localized swelling brought on by the release of histamine. Itching is rare, and usual areas of appearance include the hands, feet, face, and genitalia, with periorbital swelling being the most often. The main objective of this review article is to study in brief the classifications, etiology, pathophysiology, and clinical trial data by describing the recent advancement in the treatment of angioedema. Various research articles obtained from different journals indexed under Scopus and SCI were used to prepare the review article and for illustrative work software such as Biorender and Microsoft Word was used. Histaminemediated angioedema, linked to allergic reactions, coexists with urticaria. Bradykinin-mediated angioedema, exemplified by hereditary angioedema and acquired forms, lacks urticaria. Idiopathic angioedema, with uncertain etiology. Imitated angioedema results from non-IgE-mediated reactions, often induced by medications. It is a complicated medical condition with a variety of causes and mechanisms. Over time, outcomes for patients have been greatly improved by a growing understanding of its etiology, pathophysiology, and available treatments. The field of medical treatment for this difficult problem is always changing, and this is partly due to clinical trials.
- 19 September 2022
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 32 (5) , 796-804
Elucidation of the Anticancer Potential of Selected Citrus Flavonoids Against NEDD4-1 in Breast Cancer
- 19 September 2022
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 32 (5) , 796-804
Elucidation of the Anticancer Potential of Selected Citrus Flavonoids Against NEDD4-1 in Breast Cancer